Illumina Stock Buy Hold or Sell Recommendation
| ILMN Stock | USD 124.46 4.21 3.50% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Illumina is 'Strong Sell'. Macroaxis provides Illumina buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Illumina positions. The advice algorithm takes into account all of Illumina's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Illumina's buy or sell advice are summarized below:
Real Value 90.86 | Target Price 186.44 | Hype Value 124.46 | Market Value 124.46 | Naive Value 120.23 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Illumina given historical horizon and risk tolerance towards Illumina. When Macroaxis issues a 'buy' or 'sell' recommendation for Illumina, the advice is generated through an automated system that utilizes algorithms and statistical models.
Illumina |
Execute Illumina Buy or Sell Advice
The Illumina recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Illumina. Macroaxis does not own or have any residual interests in Illumina or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Illumina's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Illumina Trading Alerts and Improvement Suggestions
| Illumina generated a negative expected return over the last 90 days | |
| The company currently holds 2.26 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Illumina until it has trouble settling it off, either with new capital or with free cash flow. So, Illumina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Illumina sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Illumina to invest in growth at high rates of return. When we think about Illumina's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 4.5 B. Net Loss for the year was (1.16 B) with profit before overhead, payroll, taxes, and interest of 3.15 B. | |
| Over 95.0% of Illumina shares are owned by institutional investors | |
| Latest headline from businesswire.com: Moonwalk Biosciences to Present Data Showcasing EpiRead and EpiWrite Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024 |
Illumina Returns Distribution Density
The distribution of Illumina's historical returns is an attempt to chart the uncertainty of Illumina's future price movements. The chart of the probability distribution of Illumina daily returns describes the distribution of returns around its average expected value. We use Illumina price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Illumina returns is essential to provide solid investment advice for Illumina.
| Mean Return | -0.11 | Value At Risk | -3.83 | Potential Upside | 3.65 | Standard Deviation | 2.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Illumina historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Illumina Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Alliancebernstein L.p. | 2023-12-31 | 2.7 M | Amvescap Plc. | 2023-12-31 | 2.6 M | Guardcap Asset Management Limited | 2023-12-31 | 2 M | Capital World Investors | 2023-12-31 | 2 M | Norges Bank | 2023-12-31 | 1.9 M | Goldman Sachs Group Inc | 2023-12-31 | 1.7 M | Nuveen Asset Management, Llc | 2023-12-31 | 1.7 M | Bank Of America Corp | 2023-12-31 | 1.5 M | Amundi | 2023-12-31 | 1.5 M | Vanguard Group Inc | 2023-12-31 | 18.2 M | Blackrock Inc | 2023-12-31 | 13.3 M |
Illumina Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 898M | (232M) | (578M) | 779M | (963M) | (914.9M) | |
| Free Cash Flow | 842M | 891M | 337M | (74M) | 281M | 263.2M | |
| Depreciation | 188M | 187M | 251M | 394M | 432M | 453.6M | |
| Other Non Cash Items | (138M) | (147M) | (994M) | 3.9B | 949M | 996.5M | |
| Capital Expenditures | 209M | 189M | 208M | 466M | 196M | 131.7M | |
| Net Income | 990M | 656M | 762M | (4.4B) | (1.2B) | (1.1B) | |
| End Period Cash Flow | 2.0B | 1.8B | 1.2B | 2.0B | 1.0B | 673.0M | |
| Change To Inventory | 25M | (12M) | (58M) | (135M) | (20M) | (21M) | |
| Change To Netincome | 105M | 124M | (288M) | 4.1B | 4.7B | 4.9B | |
| Dividends Paid | 5M | 735M | 511M | 937M | 1.1B | 1.1B | |
| Investments | 1.0B | (143M) | (1.1B) | (591M) | (231M) | (242.6M) | |
| Change Receivables | (58M) | 89M | (164M) | (12M) | (10.8M) | (11.3M) | |
| Net Borrowings | 731M | (550M) | 471M | 991M | 1.1B | 1.2B |
Illumina Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Illumina or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Illumina's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Illumina stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.12 | |
β | Beta against NYSE Composite | 0.07 | |
σ | Overall volatility | 2.35 | |
Ir | Information ratio | -0.08 |
Illumina Volatility Alert
Illumina exhibits very low volatility with skewness of 0.06 and kurtosis of -0.57. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Illumina's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Illumina's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Illumina Implied Volatility
Illumina's implied volatility exposes the market's sentiment of Illumina stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Illumina's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Illumina stock will not fluctuate a lot when Illumina's options are near their expiration.
Illumina Fundamentals Vs Peers
Comparing Illumina's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Illumina's direct or indirect competition across all of the common fundamentals between Illumina and the related equities. This way, we can detect undervalued stocks with similar characteristics as Illumina or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Illumina's fundamental indicators could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Illumina to competition |
| Fundamentals | Illumina | Peer Average |
| Return On Equity | -0.19 | -0.31 |
| Return On Asset | -0.0053 | -0.14 |
| Profit Margin | (0.26) % | (1.27) % |
| Operating Margin | (0.03) % | (5.51) % |
| Current Valuation | 20.73 B | 16.62 B |
| Shares Outstanding | 159.26 M | 571.82 M |
| Shares Owned By Insiders | 0.24 % | 10.09 % |
| Shares Owned By Institutions | 94.83 % | 39.21 % |
| Number Of Shares Shorted | 5.27 M | 4.71 M |
| Price To Earning | 49.12 X | 28.72 X |
| Price To Book | 3.52 X | 9.51 X |
| Price To Sales | 4.49 X | 11.42 X |
| Revenue | 4.5 B | 9.43 B |
| Gross Profit | 3.15 B | 27.38 B |
| EBITDA | (1.07 B) | 3.9 B |
| Net Income | (1.16 B) | 570.98 M |
| Cash And Equivalents | 2.01 B | 2.7 B |
| Cash Per Share | 6.62 X | 5.01 X |
| Total Debt | 2.26 B | 5.32 B |
| Debt To Equity | 0.38 % | 48.70 % |
| Current Ratio | 0.93 X | 2.16 X |
| Book Value Per Share | 36.13 X | 1.93 K |
| Cash Flow From Operations | 477 M | 971.22 M |
| Short Ratio | 3.36 X | 4.00 X |
| Earnings Per Share | (7.34) X | 3.12 X |
| Price To Earnings To Growth | 4.30 X | 4.89 X |
| Target Price | 152.15 | |
| Number Of Employees | 10.59 K | 18.84 K |
| Beta | 1.19 | -0.15 |
| Market Capitalization | 19.81 B | 19.03 B |
| Total Asset | 10.11 B | 29.47 B |
| Retained Earnings | (19 M) | 9.33 B |
| Working Capital | 1.04 B | 1.48 B |
Note: Acquisition by Ullem Scott B. of 163 shares of Illumina at 137.682 subject to Rule 16b-3 [view details]
Illumina Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Illumina . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Illumina Buy or Sell Advice
When is the right time to buy or sell Illumina? Buying financial instruments such as Illumina Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 2.5B | 3.5B | 2.3B | 2.4B | Total Assets | 15.2B | 12.3B | 10.1B | 10.6B |
Use Investing Ideas to Build Portfolios
In addition to having Illumina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Illumina Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Illumina Stock analysis
When running Illumina's price analysis, check to measure Illumina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Illumina is operating at the current time. Most of Illumina's value examination focuses on studying past and present price action to predict the probability of Illumina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Illumina's price. Additionally, you may evaluate how the addition of Illumina to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Illumina's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (7.34) | Revenue Per Share 28.506 | Quarterly Revenue Growth 0.036 | Return On Assets (0.01) |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.